Single-dose vaccine production speeds up

Advanced Search

The story appears on

Page A2

April 8, 2021

GET this page in PDF

Free for subscribers

View shopping cart

Single-dose vaccine production speeds up

By Zhu Shenshen | 00:00 UTC+8 April 8, 2021 |

Print Edition

CHINA is speeding up production of a single-dose COVID-19 vaccine in Shanghai, with annual production capacity of about 200 million units, it was revealed at the Shanghai Global Investment Promotion Conference.

Shanghai Pharmaceuticals CanSino Biologics will produce the one-shot vaccines in a factory in Baoshan District with an investment of 400 million yuan (US$62.5 million). Total investment in the project, which will cover COVID-19 and other vaccines, will reach 1.5 billion yuan. In February, CanSino announced that it has received conditional marketing approval for its single dose Recombinant Novel Coronavirus Vaccine, or Convidecia.

Business

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Single-dose vaccine production speeds up

Email this to your friend